Updated Terms of Use & Privacy Policy

We’ve updated our Terms of Use, and Privacy Policy. Please take a moment to review the changes.

Metastatic NSCLC with ROS1 Rearrangement and Multiple Acquired Resistance Mechanisms to Tyrosine Kinase Inhibitor Therapy: Chasing the Target

shaverdashvili full page

Download (1.32 MB)

General

Metastatic NSCLC with ROS1 Rearrangement and Multiple Acquired Resistance Mechanisms to Tyrosine Kinase Inhibitor Therapy: Chasing the Target

Khvaramze Shaverdashvili, MD
Timothy F. Burns, MD, PhD
United States